Study Links Low Vitamin D to Increased Pain and Opioid Use After Breast Cancer Surgery

Salt Lake City, UT, September 14, 2026 — A recent study indicates a potential link between low vitamin D levels and increased post-operative pain and opioid consumption in patients undergoing breast cancer surgery. The research, published in the journal Regional Anesthesia & Pain Medicine and subsequently highlighted by Science Daily, was conducted by researchers from Egypt.

The study’s findings suggest that individuals with a deficiency in vitamin D experienced more moderate levels of pain and required higher doses of opioid medication following their surgical procedures. This association points to vitamin D’s possible role in pain management strategies, particularly in the context of surgical recovery.

While the exact mechanisms are still under investigation, the researchers theorize that vitamin D may influence pain perception and management due to its known anti-inflammatory properties and its effects on the broader immune system. These biological roles could extend to modulating the body’s response to surgical trauma and pain.

The implications of these findings may extend beyond the immediate post-operative period, suggesting that vitamin D status could be a factor to consider in comprehensive patient care and recovery protocols. Further research may explore how optimizing vitamin D levels could potentially impact patient outcomes, including pain levels and the need for analgesics.

The names of the specific researchers leading the study were not provided in the summary. The exact methodology used to measure vitamin D levels, pain intensity, and opioid usage was also not detailed.

Story summarized from the original created by Lois M. Collins on www.deseret.com, see more information here.

Media gallery